SCHEMBL4184907

SCHEMBL4184907

O=C(O)N1CCC(C=Cc2ccc(O)c([N+](=O)[O-])c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH5A1 P51649 1/20 0.48
ABAT P80404 1/20 0.48
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
POLB P06746 2/20 0.43
EGFR P00533 1/20 0.42
GSK3B P49841 2/20 0.41
MAPT P10636 6/20 0.40
KDM4E B2RXH2 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 5/20 0.39
MAPK1 P28482 3/20 0.39
NPC1 O15118 2/20 0.39
ITGB2 P05107 1/20 0.39
ICAM1 P05362 1/20 0.39
ITGAL P20701 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184900 1.00 ALDH5A1 (0.48) ALDH5A1ABATMEN1KMT2APOLB
SCHEMBL4184903 1.00 ALDH5A1 (0.48) ALDH5A1ABATMEN1KMT2APOLB
SCHEMBL13927879 0.85 ALDH5A1 (0.50) ALDH5A1ABATMEN1KMT2APOLB
SCHEMBL4187138 0.84 ALDH1A1 (0.43) ALDH5A1ABATMAPTKDM4EL3MBTL1
SCHEMBL4187142 0.84 ALDH1A1 (0.43) ALDH5A1ABATMAPTKDM4EL3MBTL1
SCHEMBL29021241 0.82 ALDH1A1 (0.44) KMT2AEGFRMAPTKDM4ENPSR1
SCHEMBL29021242 0.82 ALDH1A1 (0.44) KMT2AEGFRMAPTKDM4ENPSR1
SCHEMBL13927919 0.81 ALDH5A1 (0.46) ALDH5A1ABATMEN1KMT2APOLB
SCHEMBL14782763 0.81 ALDH1A1 (0.46) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL15953653 0.81 ALDH1A1 (0.46) MEN1KMT2APOLBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042874-A1 ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS WYETH (US) 2009-02-12 US disclosed
WO-2008150848-A1 ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS WYETH (US) 2008-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042874-A1 ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS HTR5A, CRH, CYP17A1 ALDH5A1 296/4885ABAT 240/4885MEN1 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.